Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment

Dendritic cells (DCs) are the most potent antigen-presenting cells and are the key initiator of tumor-specific immune responses. These characteristics are exploited by DC therapy, where DCs are ex vivo loaded with tumor-associated antigens (TAAs) and used to induce tumor-specific immune responses. U...

Descripción completa

Detalles Bibliográficos
Autores principales: Belderbos, Robert A., Aerts, Joachim G.J.V., Vroman, Heleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475716/
https://www.ncbi.nlm.nih.gov/pubmed/31020037
http://dx.doi.org/10.1016/j.omto.2019.03.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475716/
https://www.ncbi.nlm.nih.gov/pubmed/31020037
http://dx.doi.org/10.1016/j.omto.2019.03.007

Ejemplares similares